AI-Powered Clinical Decision Support and Diagnostic Imaging Analysis

PharmEasy, one of India's largest digital healthcare platforms headquartered in Mumbai, has deployed AI clinical decision support systems and computer vision diagnostic tools across its teleconsultation and diagnostic testing services. The company's AI-powered symptom checker, built on a fine-tuned large language model trained on medical literature and validated by licensed physicians, guides patients through structured symptom assessment and recommends appropriate care pathways including teleconsultation, in-person visits, or emergency services. For diagnostic imaging, PharmEasy has integrated AI algorithms that analyze chest X-rays, CT scans, and pathology slides to assist radiologists and pathologists in detecting abnormalities including lung nodules, fractures, and diabetic retinopathy. The company's AI radiology platform uses convolutional neural networks trained on datasets of over 5 million annotated medical images from Indian patient populations to achieve diagnostic accuracy rates comparable to board-certified radiologists for priority conditions. PharmEasy's AI also powers its medicine recommendation engine, which cross-references patient prescription histories, drug interaction databases, and adverse event registries to flag potential medication errors and suggest generic substitutions. The platform serves over 50 million registered users and processes over 100,000 diagnostic tests daily, with AI systems operating as a safety layer across the entire patient journey from symptom assessment to result delivery.